A study to evaluate if a new drug is effective in preventing the progression of lung fibrosis

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-001571-36

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is: To determine the effect of GS-6624 on progression free survival (PFS) as determined by either a categorical decline in forced vital capacity (FVC) and all cause mortality, in all subjects enrolled or in a subset of subjects who are classified as Lysyl Oxidase-like-2 (LOXL2) High based on a pre-specified level in serum at baseline.


Critère d'inclusion

  • Idiopathic pulmonary fibrosis